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Abstract
The complex hexakis (N-methylimidazole) copper(II) salicylate, ½CuðN -meimÞ6ðsalÞ2, has been prepared from the reaction of
copper(II) aspirinate with N -methylimidazole and was crystallographically and spectroscopically characterized. The complex
crystallizes in the space group P21=c with a ¼ 13:324ð2Þ, b ¼ 7:870ð1Þ and c ¼ 20:039ð3Þ A and b ¼ 108:41ð1Þ. It is structure
that of a tetragonally distorted octahedral copper(II) cation with six coordinated N-methylimidazole ligands and two salicylate
counter ions. The superoxide dismutase (SOD) mimetic activity of the complex has been investigated by utilizing xan-
thine–xanthine oxidase assay. The results indicate that the complex is potent SOD mimic.  2002 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Copper complexes of salicylic acid and its deriva-
tives have attracted considerable interest because they
found to have a variety of pharmacological eﬀects in-
cluding antitumor and antiinﬂammatory eﬀects [1–3].
These binary complexes and their ternary complexes
with basic ligands are often more eﬀective and desirable
drugs than the parent drugs [4]. They can exist as
dinuclear or mononuclear species depending on the
reaction conditions and on the addended base ligand
[2–14]. For example, copper(II) aspirinate and its sol-
vates with the weakly basic ligands DMF, H2O,
DMSO or CH3OH contain binuclear units with
bridging carboxylates, thus, these complexes are similar
to many other copper(II) carboxylate dimers [2,5–7,10].
Mononuclear copper(II) complexes of salicylate deriv-
atives with basic ligands containing nitrogen donors
have been previously reported and were found to exist
in a variety of structures [3,5,8–14]. While the com-
plexes with imidazole and N -methylimidazole are
known to exist as bis- and tetrakis-adducts [8,10,12],
those of 1,2-dimethylimidazole, benzimidazoles and
pyridines are only known as bis-adducts [8,9,11,13].
This diﬀerence in behavior may attributed, in part, to
the steric restrictions imposed by the ligands in the
later bis-adducts.
As a continuation of our work on the interaction of
copper(II) carboxylates of the antiinﬂammatory drugs
with imidazoles [8,9,15] as models for copper proteins
that contain both the imidazole and carboxylate
functionalities in the side chain [16], we recently
reported the synthesis and X-ray structural character-
ization of a mixture of bis-, pentakis- and hexakis-
imidazole adducts of copper(II) salicylate [17]. Herein
we report the synthesis and X-ray structural charac-
terization of hexakis (N -methylimidazole) copper(II)
salicylate. Because the antiinﬂammatory and antican-
cer eﬀect of copper(II) salicylate and other copper(II)
complexes may be attributed to their superoxide
dismutase (SOD) activity [1,4,18], we examined the
SOD like activity of this complex and compared to the
activity of native SOD and other copper(II) com-
plexes.
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2. Experimental
2.1. Reagent and materials
All chemicals were of high purity grade (Aldrich or
Sigma chemical) and were used without further puriﬁ-
cations. Tetrakis-l-aspirinato dicopper(II) ½Cu2ðaspÞ4
was prepared as previously described [19].
2.2. Preparation of hexakis (N -methylimidazole) cop-
per(II) salicylate, [Cu (N -meim)6] (sal)2
A 0.50 g (0.59 mmol) of copper(II) aspirinate was
stirred with 5 ml of anhydrous N -methylimidazole in an
ice bath for 4 h. The blue solution was concentrated by
slow evaporation in a hood to ca. 2 ml. Slow diﬀusion of
anhydrous diethylether into the blue solution produced
blue–violet crystals. Anal. Calc: C, 54.97; H, 5.54; N,
20.25. Found: C, 54.85; H, 5.48; N, 20.14%.
2.3. Physical measurements
The IR, UV–visible, and magnetic moment mea-
surements were obtained as previously described [9].
Elemental analysis were performed by Galbraith Labo-
ratories, Knoxville, TN, USA.
2.4. X-ray structure determination
The method for obtaining and acquisition of crytal-
lographic data was as described previously [17]. A
summary of these data is given in Table 1. Blue–violet
crystals of the complex were grown from the neat ligand,
N -methylimidazole. The unit cell parameters were ob-
tained from the least-squares ﬁt of 47 reﬂections. Data
were collected over the range of indices 06 h6 21,
06 k6 8, 146 l6 13 (3:56 2h6 45). Of the 2631
unique reﬂections measured, 2172 with F0 > 4:0rðF0Þ
were used during full-matrix least-squares reﬁnement.
The weighting scheme used was w1 ¼ r2ðF Þþ
0:0008F 2. The largest peak in the ﬁnal diﬀerence map
was 0:77 A
3
.
2.5. Superoxide dismutase assay
Superoxide dismutase activity was assayed using the
xanthine–xanthine oxidase system for the production of
superoxide and iodophenyl–nitrophenyl–phenyltetrazo-
lium salt (INT) reduction at 510 nm for the superoxide
detection [20]. The reaction mixture contained
8:5 105 M xanthine and 1:5 104 M INT in 0.05 M
phosphate buﬀer solution at pH 7.8. The reaction was
started by the addition of xanthine oxidase in the
amount needed to yield an absorbance change of 0.03–
0.04 units per minute at 510 nm in the absence of the
copper complex. The SOD mimetic activity of the cop-
per complex at 25 C was evaluated from the absorbance
decrease at 510 nm comparing to the blank (the reaction
mixture without the copper complex). A unit SOD ac-
tivity is the concentration of the complex or enzyme
which causes 50% inhibition reduction of INT (the IC50
value).
3. Results and discussion
3.1. Spectroscopic and magnetic results
The mononuclear complex ½CuðN -meimÞ6ðsalÞ2 is the
product of slow reaction of dinuclear copper (II) aspi-
rinate with N -methylimidazole. During the reaction and/
or recrystallization the acetoxy group of the coordinated
aspirinate ligands undergoes hydrolysis to give the non-
coordinated salicylate ligands. The stretching frequency
of the acetoxy carbonyl moiety of the aspirinate ligands
occurs near 1750 cm1 for mononuclear copper (II)
aspirinate adducts and at 1758 and 1725 cm1 for the
dinuclear copper(II) aspirinate [8–11]. The complex does
not exhibit a C@O stretching frequency in this region,
suggesting that the acetoxy group has been lost. This is
conﬁrmed by the solid state structures (vide infra). The
IR frequencies of the non-coordinated salicylate ions in
the complex found at 1630, 1585 and 1570 cm1 are
assigned to mðC@CCÞ of the phenyl and to asymmetric
masðCOOÞ vibrations. The symmetric stretching
msðCOOÞ and the symmetric bending dsðCOOÞ fre-
quencies occur at 1385 and 665 cm1, respectively. The
frequencies at 1244 and 810 cm1 are assigned to
mðCuAOHÞ and to dðCuAOHÞ þ mðCuACOOÞ vibra-
tions, respectively. The positions of these IR vibrations
Table 1
Crystal data for ½CuðN -meimÞ6ðsalÞ2.
Chemical formula C38H46N12O6Cu
Fw 830.0
Space group P21 /c
Z 2
a, A 13.324(2)
b, A 7.870(1)
c, A 20.039(3)
a, deg 90.00
b, deg 108.41(1)
c, deg 90.00
V , A
3
1993.7(5)
d (calcd), g=cm3 1.463
Radiation, k, A Mo; 0.71073
Temp, C )100
abs coeﬀ, cm1 6.11
aR, % 5.75
bRw, % 7.06
GOF 1.86
aR ¼ RjjF0j  jFcjj=RjF0j.
bRw ¼ ½RwðjF0j  jFcjÞ2=RwjF0j21=2.
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are comparable to those reported for salicylate mono-
anion [17,21].
The visible electronic spectrum of the compound
obtained in methanol solution exhibits two absorption
bands. The broad band at 634 nm
ð€ ¼ 78 dm3 mol1 cm1Þ corresponds to a ligand-ﬁeld
transition characteristic of elongated tetragonal octa-
hedral stereochemistry having CuN4 
 
 
N2 chromo-
phore [17,22]. The band at 410 nm
ð€ ¼ 96 dm3 mol1 cm1Þ can be considered a charge-
transfer transition. A similar band between 400 and 450
nm attributed to ligand-to-metal charge transfer was
previously observed for mononuclear copper(II) salicy-
late complexes [5,17]. The room temperature magnetic
moment of the compound is 1.87 BM. This value is
consistent with the presence of one unpaired electron in
mononuclear copper(II) ion complexes.
3.2. Crystal structure
The complex, ½CuðN -meimÞ6ðsalÞ2, crystallizes as
blue irregular crystals in P21=c with the copper(II) ion
located on an inversion center. The complex consists of
a hexakis (N -methylimidazole) copper(II) cation and
non-coordinated salicylate anions. The structure of the
cation (Fig. 1) is that of a tetragonally elongated octa-
hedron. The four short Cu–N distances in the equatorial
plane; Cu–N(1) is 2.009 A and Cu–N(2) is 2.004 A, and
are comparable to inner sphere Cu–N distances found in
other imidazole copper(II) carboxylate complexes
[12,17,22,23] including those reported for
CuðN -meimÞ2ðsalÞ2 [12]. The two long distances Cu–
N(6) and Cu–N(6A) in the complex are 2.697 A. This
value compares favorably with the long Cu–O distances
of 2.649 A found in the tetragonally distorted
CuðImÞ4ðOAcÞ2 (Im¼ imidazole, OAc¼ acetate) [23].
The four closest N -meim ligands in the complex are
oriented such that they twisted out of the vertical planes
of the core octahedron. The least-squares plane of the
trans-N -meim ligands that contain N(2) and N(2A)
makes a dihedral angle of 21.4 with the core vertical
plane deﬁned by N(6), Cu, and N(2). The least-squares
plane of the other close trans-N -meim ligands that
contain N(1) and N(1A) forms a dihedral angle of 42.8
with the core vertical plane deﬁned by N(1), Cu and
N(6). The orientation of the nearest N -methylimidazole
ligands in the complex diﬀers signiﬁcantly from that of
the hexakis-imidazole adduct, ½CuðImÞ6ðsalÞ2, which
has a similar tetragonally distorted octahedral geometry
[17]. While all four of the N -meim ligands in
½CuðN -meimÞ6ðsalÞ2 are twisted out of the copper
square plane, two of the closest imidazole ligands in
½CuðImÞ6ðsalÞ2 are nearly in the square plane and the
least-squares plane of the other two is nearly perpen-
dicular to the square plane [17]. It is also interesting to
note that the long Cu–N distances in ½CuðImÞ6ðsalÞ are
shorter by ca. 0.25 A that the analogous bonds in
½CuðN -meimÞ6ðsalÞ2. It is not clear whether these dif-
ferences are due to diﬀerences in the electronic nature of
the two complexes or in steric and/or packing phe-
nomena.
3.3. Superoxide dismutase activity
The superoxide dismutase-like activity of the complex
has been measured using the indirect xanthine–xanthine
oxidase–INT method [20]. Fig. 2 shows the percentage
inhibition of the reduction of INT plotted against the
concentration of the complex ½CuðN -meimÞ6ðsalÞ2. Ta-
ble 2 shows the IC50 value of the complex and the cor-
responding values of other copper(II) complexes with
salicylate type ligand and with imidazole ligands and of
the native Cu, Zn-SOD-enzyme. In comparison to other
copper(II) complexes including salicylate type com-
plexes which were previously demonstrated as SOD
mimics [10,20,24,25], the complex tested in this work has
higher activity. It has an activity about 42 times less than
that of the native Cu, Zn-SOD. The complex is potent
SOD mimics considering the very low molecular weight
of the complex when compared to that of the native
SOD enzyme (MW¼ 31200 D). Some factors were
proposed which may involve in the diﬀering dismutation
abilities shown by diﬀerent copper complexes in vitro. A
fast exchange of molecules axially linked to the center,
Fig. 1. Structure of the cation of ½CuðN -meimÞ6ðsalÞ2. Hydrogen at-
oms have been omitted for clarity.
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limited steric hindrance to the approach of the super-
oxide anion, and the presence of co-ordination site be-
longing to nitrogen heteroatomic rings such as
imidazoles or pyridines are important for high SOD
activity [24–26]. Moreover, the distorted geometry of the
copper complexes may favor the geometrical change,
which is essential for the catalysis as the geometry of
copper(II) in SOD changes from distorted square py-
ramidal to distorted tetrahedral copper (I) during ca-
talysis [27]. These requirements are satisﬁed in the
tetragonally distorted complex, ½CuðN -meimÞ6ðsalÞ2. In
this complex which contains the CuN4 
 
 
N2 chromo-
phore, the weakly coordinated N -methylimidazole mol-
ecules in the axial positions are readily dissociated to
provide sites on Cu(II) for O2 bonding and the disso-
ciation would also facilitate any necessary geometrical
changes induced by O2 bonding. In addition, the rela-
tively high SOD-like activity of the complex under in-
vestigation may be also attributed to the coordination of
four imidazole nitrogen atoms to copper(II) atom in the
equatorial plane similar to the coordination site of
Cu(II) in the native enzyme Cu, Zn-SOD.
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